December Newsletter

*|MC:SUBJECT|*
A reminder of who we are

We are a collective of freelance interdisciplinary artists dedicated to working on projects orientated towards social change and improving human wellbeing. Through following the voices of researchers, medical professionals, and psychedelic-users, our documentary is an education source for the potential uses of psychedelics in healing and mental health and a commentary on the political and social changes within the psychedelic sphere.

We are expanding our Psychedelic Renaissance project as a platform for information exchange of current events and movements in the ongoing revolution. By doing so, together, we can stand from a place of well-rounded, non-bias information while opening the conversations around psychedelic drugs.
 

The Psychedelic Renaissance

Project Updates 

Monthly Newsletters 


We are delighted to be sending the first of our ongoing monthly newsletters. Here, we will share highlights from this month’s psychedelic news and science with our like-minded followers, as well as updates on the project, a dedication to one of our project contributors, and exciting upcoming events.


Blog Posts


We are also thrilled to announce we will now be releasing blog content, covering a wide variety of topics, all relating to the psychedelic movement. Click to read our first blog piece. 


Find us on Twitter


We have recently moved onto Twitter. To keep your feed updated with Tweets relevant to psychedelic research, culture and science find us at @PsycRenaissance.

November News and Science


Coming closer to ending the war on drugs in the United States

New state laws: On the 4th November, a nationwide push to relax the drug wars in the US ended in success. Oregon became the first official US state to decriminalise small possession amounts of illegal drugs including heroin, cocaine and psychedelics, in a similar model to the decriminalisation laws in Portugal. Voters in Arizona, Montana, New Jersey and South Dakota passed legislation of recreational cannabis, joining the eleven other US states where recreational cannabis is already legal. 

The voting majority indicates public desire to re-address the outdated drug laws and with these new laws in place, we hope to see a decrease in crime related to the illicit cannabis market and less people discriminated against for drug use.



New presidency: The results from the November 3rd election ended in Joe Biden being voted as the 46th president of the US. Unlike his predecessor, Donald Trump, Biden has reported a much more relaxed and open stance to the war on drugs. Biden has openly supported decriminalising cannabis at a federal level, admitted “anti-drug policies have harmed black-communities and it has been a mistake to support them”, and believes drug-users should receive treatment and be supported instead of being punished.


The role of mystical experience and entity encounters in the psychedelic therapy

This research article, published November 11th, investigates scientific experiments looking at mystical experiences and entity encounters in psychedelic therapy. Experimental data suggests if patients have mystical experiences, including the experience of unity and transcending time and space, they will likely have a better outcome in psychedelic therapy. Could psychedelic reports of meeting alien-like entities also promote healing? Entity encounters indicate a lost touch with reality which can be fearful and have detrimental consequences for some. But perhaps in a psychedelic therapy context, these non-worldly mystical beings may promote healing.



Machine Elf by Luke Brown: an art depiction of an entity encountered whilst on the psychedelic drug, DMT
 

Rapid and sustained effects from psilocybin in major depressive disorder

Twenty-four patients suffering from major depression took part in a recent study by Johns Hopkins University. After one week the patients' depression scores had dropped by 71% and the decrease in depression was maintained after one-month following the treatment. These results show psilocybin-therapy is an effective treatment with more rapid and prolonged effects than current psychiatric drugs. We hope to keep finding promising data like this, with the long-term hope that current psychiatric methods are re-evaluated and people suffering from depression can have open access to more effective treatments like psilocybin therapy.


Drug use during COVID-19

With a second national lockdown in place as of November the 5th, how is the pandemic affecting drug use? This article gives us an insight into what we know so far and what we're yet to know, with the help of online survey participants. To read or take part in a survey visit this page.

Results from the Global Drug Survey Report 2020: Change in frequency of use of various drugs since before COVID-19

Our Contributors and Partners

 

Dr Ben Sessa


We have followed the work of Dr Ben Sessa for three years. He is a crucial figure in our documentary and a pioneering advocate for psychedelic-assisted psychotherapy.

Dr Sessa is a qualified psychiatrist. He worked as a consultant for eight years, gaining interest in the ties between trauma in children, adult mental disorders and substance abuse. With a passion in psychedelics, he has research ties at Imperial College London University and Bristol University, where he conducted the world’s first clinical study using MDMA-assisted psychotherapy to treat alcohol addiction. He is also the founder of the biannual Breaking Convention, one of the world's largest psychedelic conferences. He has widely published work in the academic and scientific press as well as fiction and non-fiction books.

Founder of Awakn Life Sciences, Dr Sessa is in the process of opening the UK’s first fully legal and licensed clinic for ketamine-assisted psychotherapy. With predictions to expand into MDMA and psilocybin use, the new clinic will be a new hub for psychedelic therapy and psychedelic research. Read more more in our blog article here.
 

A still from our documentary of Dr Sessa in his home 

Events

On behalf of our partners, the Psychedelic Society, here are some upcoming events featuring our proud contributors and project team members.

Tibetan Dream Yoga - 7th December 

This unique event will introduce you with ways to harness the power of your dreams with inspiration from an ancient Tibetan buddhism-based practice, whilst learning about the biology underpinning the dream state. By purchasing a ticket, money will be donated to the fungus conservation trust, aiding protection of fungi and overall our ecosphere.

Harm Reduction: Psychedelic Support & Danger Prevention - 16th December

With an upward trend in the number of people consuming, and the availability of psychoactive drugs, knowing, and avoiding the risks is a matter of urgency. 

Join us alongside a panel of experts from the Zendo Project, Psycare and The Loop as we discuss the strategies in place, the political and cultural barriers, and look to the future of preventing drug-related dangers.

The Natural Philosopher - A Conversation With Dennis McKenna - 20th December

Join us for this extra special event as we chat to Dr Dennis McKenna about his pioneering research, accomplishments and fascinating life-stories. Brother to the famous psychedelics proponent, Terence McKenna, Dennis has dedicated his life to plants, fungi and their healing abilities.


Occultist and writer Julian Vayne, author of Getting Higher: The Manual of Psychedelic Ceremony, was recently banned from speaking at the Oxford Psychedelic Society by the administrators at one of the University's colleges. His crime? Being on record as having taken, and advocated for, psychedelic substances.

Come and expand your mushroom cultivation knowledge and learn advanced growing techniques in this four week course designed for people who already know the basics. It is perfect for anyone who has attended any of Darren’s previous Shroomshop for Beginners.
Facebook
Twitter
Instagram
Website
Previous
Previous

The Fascinating Neuroscience of 5-MeO-DMT

Next
Next

On the MAPS: New Directions for The Psychedelic Renaissance